LS Investment Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-113
| Closed | -$12K | – | 1641 |
|
|
2020
Q1 | $12K | Sell |
113
-620
| -85% | -$65.8K | ﹤0.01% | 1496 |
|
|
2019
Q4 | $84K | Buy |
733
+36
| +5% | +$4.13K | ﹤0.01% | 1166 |
|
|
2019
Q3 | $56K | Hold |
697
| – | – | ﹤0.01% | 1272 |
|
|
2019
Q2 | $51K | Hold |
697
| – | – | ﹤0.01% | 1298 |
|
|
2019
Q1 | $65K | Hold |
697
| – | – | ﹤0.01% | 1231 |
|
|
2018
Q4 | $51K | Hold |
697
| – | – | ﹤0.01% | 1264 |
|
|
2018
Q3 | $61K | Hold |
697
| – | – | ﹤0.01% | 1262 |
|
|
2018
Q2 | $69K | Hold |
697
| – | – | ﹤0.01% | 1224 |
|
|
2018
Q1 | $83K | Hold |
697
| – | – | ﹤0.01% | 1162 |
|
|
2017
Q4 | $89K | Buy |
+697
| New | +$89K | 0.01% | 1162 |
|
|
2016
Q4 | – | Sell |
-1,208
| Closed | -$82K | – | 1866 |
|
|
2016
Q3 | $82K | Sell |
1,208
-340
| -22% | -$23.1K | 0.01% | 1061 |
|
|
2016
Q2 | $86K | Buy |
1,548
+238
| +18% | +$13.2K | 0.01% | 1041 |
|
|
2016
Q1 | $82K | Buy |
1,310
+347
| +36% | +$21.7K | 0.01% | 955 |
|
|
2015
Q4 | $91K | Hold |
963
| – | – | 0.01% | 893 |
|
|
2015
Q3 | $77K | Hold |
963
| – | – | 0.01% | 958 |
|
|
2015
Q2 | $115K | Buy |
+963
| New | +$115K | 0.01% | 829 |
|